Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital... More >>

Recent News

More >>
Cardiovascular Systems, Inc. Reports Fiscal 2018 First-Quarter Financial Results 10/25/17
Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, October 25, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $49.7 million were flat versus first quarter last year Gross margin increased to 81.5% from 81.0% in the prior-year period Net loss was $(2.0) million, or $(0.06) per basic share LIBERTY 360° one-year data demonstrates compelling, long-term benefits following endovascular intervention in patients with critical limb ischemia (CLI) Saline infusion pump recall was completed Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal first quarter ended September 30, 2017 . The company’s first-quarter revenues were $49.7 million, a decrease of $0.1 million from the first quarter of fiscal 2017. Gross profit margin rose to 81.5% from 81.0% driven primarily by unit cost...
More >>
Cardiovascular Systems to Webcast Fiscal 2018 First-Quarter Earnings Conference Call Wednesday, October 25 10/04/17
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 first-quarter conference call on Wednesday, October 25, 2017, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss CSI’s results for its fiscal first quarter ended September 30, 2017, and its financial outlook. The company will issue a post-market earnings release prior to the call on October 25. To access the live webcast, go to the events section of the company’s investor relations website, http://investors.csi360.com/Investors/Events , on the day of the conference call and click on the webcast link. A webcast replay will be available beginning at 6:45 p.m. CT the same day. To participate in the conference call, dial (833) 241-7255 and enter 95692520. Please dial in at least 10 minutes prior to the call. About Cardiovascular Systems, Inc. ...
More >>

Upcoming Events

No items found